IP Library Granted Patent US 8,999,689
Granted Patent B2
US 8,999,689 · App. 13/770,252 · Granted Apr 7, 2015

Patent

Inventors: James Rozzelle (San Francisco, CA); Elena Bolchakova (Union City, CA)
Assignee: Applied Biosystems, LLC
C12N9/1252C12Q1/686Y10S435/975
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,999,689
App. No.
13/770,252
Granted
Apr 7, 2015
Kind
B2
Abstract

The invention provides novel nucleic acid polymerases from strains GK24 and RQ-1 of Thermus thermophilus , and nucleic acids encoding those polymerases, as well as methods for using the polymerases and nucleic acids.

Claims (9)

1. An isolated mutant nucleic acid polymerase comprising SEQ ID NO: 20.

2. The isolated mutant nucleic acid polymerase of claim 1 , wherein the polymerase exhibits decreased 5-3′ exonuclease activity relative to its corresponding wild type nucleic acid polymerase.

3. The isolated mutant nucleic acid polymerase of claim 1 , wherein the polymerase exhibits reduced discrimination against dideoxynucleotide triphosphates relative to its corresponding wild type nucleic acid polymerase.

4. A kit comprising a container containing the mutant nucleic acid polymerase of claim 1 .

5. The kit of claim 4 further comprising a container containing an unlabeled nucleotide, a labeled nucleotide, a balanced mixture of nucleotides, a chain terminating nucleotide, a nucleotide analog, a buffer solution, a solution containing magnesium, a cloning vector, a restriction endonuclease, a sequencing primer, a solution containing reverse transcriptase, or a DNA or RNA amplification primer.

6. The kit of claim 4 , adapted for performing DNA sequencing, DNA amplification, reverse transcription, RNA amplification or primer extension.

7. The isolated mutant nucleic acid polymerase of claim 1 , wherein the polymerase comprises an amino acid substitution at position 46.

8. The isolated mutant nucleic acid polymerase of claim 7 , wherein the amino acid substitution at position 46 comprises a substitution with Asp.

9. The isolated mutant nucleic acid polymerase of claim 1 , wherein the polymerase is made by incubating a host cell under conditions sufficient for RNA transcription and translation of a nucleic acid encoding the polymerase operably linked to a promoter.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2013
From: ROZZELLE, JAMES E.; BOLCHAKOVA, ELENA V
To: APPLERA CORPORATION
Reel/Frame 030638/0680 →
MERGER Recorded Jun 18, 2013
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 030638/0684 →
MERGER Recorded Jun 18, 2013
From: ATOM ACQUISITION CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 030638/0691 →
MERGER Recorded Jun 18, 2013
From: ATOM ACQUISITION CORPORATION; APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 030638/0698 →
Continuity (6)
Continuation 12905008 · Oct 14, 2010
Continuation 12193691 · Aug 18, 2008
Division 11609174 · Dec 11, 2006
Division 10303110 · Nov 22, 2002
Provisional Application 60336046 · Nov 30, 2001
Related Publication 20140038187A1 · Feb 6, 2014